2 Must-Have Biotechs For The Rest Of 2017
Biotech has had a nice surge in February. Small- and mid-caps are leading the charge as M&A activity has picked up markedly so far in 2017.
from Biotech News
Biotech has had a nice surge in February. Small- and mid-caps are leading the charge as M&A activity has picked up markedly so far in 2017.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments